Complementary and Alternative Medicine for Premature Ovarian Insufficiency: A Review of Utilization and Mechanisms

Premature ovarian insufficiency (POI) is defined as a decline in ovarian function before the age of 40 and is one of the leading causes of infertility in women. The etiology is complex, and the pathogenesis is not clear. The main treatment is hormone replacement therapy, but a growing body of data confirms that such treatment can increase the risk of endometrial disease and cardiovascular disease. Complementary and alternative medicine (CAM) has been widely used in patients with POI due to its limited adverse reactions and high efficiency. According to literature reports, CAM therapy for POI mainly includes traditional Chinese medicine, acupuncture, psychotherapy, dietary supplements, and exercise therapy. This article reviews the application of CAM in the treatment of POI and attempts to determine the therapeutic effects and the mechanisms behind these effects based on existing clinical and experimental studies in order to provide theoretical support for the treatment of POI.

[1]  Zhiyin Du,et al.  Clinical Observation on the Improvement of Serum Sex Hormone and Ovarian Function in Premature Ovarian Failure Patients with Deficiency-Cold Syndrome by Combining Wenjing Decoction with Tiaobu Chongren Acupuncture and Moxibustion , 2021, Evidence-based complementary and alternative medicine : eCAM.

[2]  G. Nie,et al.  Protective effect of Huyang Yangkun Formula on ovarian function in premature ovarian insufficiency rats based on apoptotic mechanism. , 2021, Journal of ethnopharmacology.

[3]  Fengjuan Han,et al.  Complementary and Alternative Medicine for Dysmenorrhea Caused by Endometriosis: A Review of Utilization and Mechanism , 2021, Evidence-based complementary and alternative medicine : eCAM.

[4]  I. Lambrinoudaki,et al.  Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. , 2021, Best practice & research. Clinical endocrinology & metabolism.

[5]  G. Nie,et al.  Danggui Buxue Tang Rescues Folliculogenesis and Ovarian Cell Apoptosis in Rats with Premature Ovarian Insufficiency , 2021, Evidence-based complementary and alternative medicine : eCAM.

[6]  Y. Tan,et al.  [The Effect and Mechanism of Hyperin on Ovarian Reserve of Tripterygium Glycosides-Induced POI Mice]. , 2021, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[7]  Yue Chen,et al.  The Effect of Bu Shen Huo Xue Tang on Autoimmune Premature Ovarian Insufficiency via Modulation of the Nrf2/Keap1 Signaling Pathway in Mice. , 2021, Journal of ethnopharmacology.

[8]  B. Ishizuka.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI) , 2021, Frontiers in Endocrinology.

[9]  I. Lambrinoudaki,et al.  Premature ovarian insufficiency: A toolkit for the primary care physician. , 2021, Maturitas.

[10]  Chunming Li,et al.  The relationship between vitamin E level and premature ovarian insufficiency , 2021, The journal of obstetrics and gynaecology research.

[11]  Sakineh Mohammad-Alizadeh-Charandabi,et al.  The effect of selenium and vitamin E supplementation on anti-Mullerian hormone and antral follicle count in infertile women with occult premature ovarian insufficiency: A randomized controlled clinical trial. , 2020, Complementary therapies in medicine.

[12]  Yehao Luo,et al.  Auricular acupuncture for premature ovarian insufficiency , 2020, Medicine.

[13]  P. Ebeling,et al.  Musculoskeletal Health in Premature Ovarian Insufficiency. Part One: Muscle , 2020, Seminars in Reproductive Medicine.

[14]  G. Nie,et al.  Synergistic effect of Huyang Yangkun Formula and embryonic stem cells on 4-vinylcyclohexene diepoxide induced premature ovarian insufficiency in mice , 2020, Chinese Medicine.

[15]  A. Carr,et al.  Global Vitamin C Status and Prevalence of Deficiency: A Cause for Concern? , 2020, Nutrients.

[16]  Jiafeng Lu,et al.  Vitamin C improves the therapeutic potential of human amniotic epithelial cells in premature ovarian insufficiency disease , 2020, Stem Cell Research & Therapy.

[17]  A. Carr,et al.  Discrepancies in global vitamin C recommendations: a review of RDA criteria and underlying health perspectives , 2020, Critical reviews in food science and nutrition.

[18]  Feifei Guo,et al.  [Research advances in chemical constituents and pharmacological activities of different parts of Eucommia ulmoides]. , 2020, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[19]  N. Biglia,et al.  Current Evidence of the Oncological Benefit-Risk Profile of Hormone Replacement Therapy , 2019, Medicina.

[20]  Hao Ai,et al.  Systems Pharmacology Uncovers Multiple Mechanisms of Erxian Decoction (二仙汤) for Treatment of Premature Ovarian Failure , 2019, Chinese Journal of Integrative Medicine.

[21]  Li Huang,et al.  Acupuncture for patients with premature ovarian insufficiency , 2019, Medicine.

[22]  F. Ramezani Tehrani,et al.  The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis , 2019, Climacteric : the journal of the International Menopause Society.

[23]  Yuan Yuan,et al.  [Clinical efficacy of Bushen Culuan Decoction in treating infertility due to premature ovarian insufficiency]. , 2019, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[24]  Nafeisha Kadeer,et al.  Research on the establishment of chronic stress‐induced premature ovarian failure the rat model and effects of Chinese medicine Muniziqi treatment , 2019, Molecular reproduction and development.

[25]  Chuan Hu,et al.  Inflamm-Aging: A New Mechanism Affecting Premature Ovarian Insufficiency , 2019, Journal of immunology research.

[26]  B. Męczekalski,et al.  Bone health and evaluation of bone mineral density in patients with premature ovarian insufficiency , 2018, Przeglad menopauzalny = Menopause review.

[27]  Qin Hu,et al.  One-step synthesis of fluorescent carbon dots for sensitive and selective detection of hyperin. , 2018, Talanta.

[28]  Xiao-jing Cao,et al.  A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine capsules for the treatment of premature ovarian insufficiency , 2018, Menopause.

[29]  A. Hosseini,et al.  Is the ovarian reserve influenced by vitamin D deficiency and the dress code in an infertile Iranian population? , 2018, Journal of Ovarian Research.

[30]  Wei Chen,et al.  Policies on Chinese Medicine in China May Have Enlightenments to Complementary and Alternative Medicine in the World , 2018, Chinese Journal of Integrative Medicine.

[31]  Yi-gong Fang,et al.  Systematic evaluation on the clinical efficacy of acupoint stimulation therapy for treatment of premature ovarian insufficiency on the basis of network Meta-analysis , 2017 .

[32]  R. Lobo.  Hormone-replacement therapy: current thinking , 2017, Nature Reviews Endocrinology.

[33]  L. Persani,et al.  Genetics of primary ovarian insufficiency , 2017, Clinical genetics.

[34]  P. Sarrel,et al.  Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. , 2016, Fertility and sterility.

[35]  H. Yüksel,et al.  Role of inflammation and oxidative stress in the etiology of primary ovarian insufficiency , 2016, Turkish journal of obstetrics and gynecology.

[36]  R. Cífková,et al.  ESHRE Guideline: management of women with premature ovarian insufficiency. , 2016, Human Reproduction.

[37]  A. Kauffman,et al.  Title: Corticosterone Blocks Ovarian Cyclicity and the Lh Surge via Decreased Kisspeptin Neuron Activation in Female Mice , 2022 .

[38]  S. Mahalingaiah,et al.  Update on primary ovarian insufficiency , 2015, Current opinion in endocrinology, diabetes, and obesity.

[39]  R. Lindsay,et al.  Erratum to: Clinician’s guide to prevention and treatment of osteoporosis , 2015, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

[40]  Y. Lee,et al.  Effectiveness of Acupuncture for Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis , 2015, Evidence-based complementary and alternative medicine : eCAM.

[41]  L. Luo,et al.  Calorie restriction inhibits ovarian follicle development and follicle loss through activating SIRT1 signaling in mice , 2015, European Journal of Medical Research.

[42]  C. Orlandini,et al.  Premature ovarian insufficiency: from pathogenesis to clinical management , 2015, Journal of Endocrinological Investigation.

[43]  Małgorzata Godziejewska-Zawada.  Obesity and diabetes in menopause: prevention and therapeutic approach , 2013 .

[44]  Zhishun Liu,et al.  Electroacupuncture Modulates Reproductive Hormone Levels in Patients with Primary Ovarian Insufficiency: Results from a Prospective Observational Study , 2013, Evidence-based complementary and alternative medicine : eCAM.

[45]  C. Taner,et al.  Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency , 2013, Archives of Gynecology and Obstetrics.

[46]  S. Luoh,et al.  Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial , 2013, Osteoporosis International.

[47]  R. Chamberlain,et al.  Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solution. , 2012, Cancer control : journal of the Moffitt Cancer Center.

[48]  P. Zhou,et al.  Maternal-Restraint Stress Increases Oocyte Aneuploidy by Impairing Metaphase I Spindle Assembly and Reducing Spindle Assembly Checkpoint Proteins in Mice1 , 2012, Biology of reproduction.

[49]  M. Kumar,et al.  Chromosomal abnormalities & oxidative stress in women with premature ovarian failure (POF) , 2012, The Indian journal of medical research.

[50]  S. Narod.  Hormone replacement therapy and the risk of breast cancer , 2011, Nature Reviews Clinical Oncology.

[51]  L. Luo,et al.  Resveratrol, an effective regulator of ovarian development and oocyte apoptosis , 2011, Journal of endocrinological investigation.

[52]  M. Kumar,et al.  Oxidative stress and ATPase6 mutation is associated with primary ovarian insufficiency , 2010, Archives of Gynecology and Obstetrics.

[53]  N. Aaronson,et al.  Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: design of a multicenter trial , 2009, BMC women's health.

[54]  Z. Valenta,et al.  Proinflammatory status, genetics and atherosclerosis. , 2009, Physiological research.

[55]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[56]  E. Pasquali.  Premature menopause and self-concept disjunctions. A case for crisis management. , 2002, Journal of psychosocial nursing and mental health services.